Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...
In metastatic prostate cancer, AI-facilitated quantification of metastatic burden, accurate identification of castration resistance, and prediction of treatment sensitivity and resistance are active ...
OMAHA, Neb. and BELGRADE, Maine, May 27, 2025 /PRNewswire/ -- The recent announcement that a former president of the United States developed late-stage prostate cancer is a distressing reminder of the ...
A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage caused by certain cancer treatments. The kidneys begin to shrink slightly—months ...
Prostate cancer is the most common form of cancer among men in Western countries. The disease is naturally linked to aging. Professor Tone Frost Bathen at NTNU leads a number of research projects on ...
Add Yahoo as a preferred source to see more of our stories on Google. Sir Chris Hoy is one celebrity calling for more screenings and awareness of prostate cancer. (Angel Martinez via Getty Images) ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has entered into letters of intent to pursue collaborations with EDAP TMS S.A. (NASDAQ: EDAP, "EDAP") and ...
Free public event during National Men’s Health Month features leading physicians addressing coronary artery disease, prostate cancer and lung cancerLOS ANGELES, May 28, 2026 (GLOBE NEWSWIRE) -- RadNet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results